Heart Failure Society Of America, FDA Seek Consensus On Trial Endpoints
This article was originally published in The Gray Sheet
Executive SummaryRepresentatives of the Heart Failure Society of America and FDA likely will meet this fall to develop an HFSA position paper on heart failure device clinical trial endpoints, HFSA says
You may also be interested in...
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.